Noteworthy - Pharmaceutical Executive



2015 Pipeline Report: Burning Bright

November 1, 2014

The science of drug discovery is back on script—and the stars are cued up for a new generation of breakthrough therapies. But is pharma ready to raise its game and cut a deal with all those "prove it to me" payers?

Health 2.0 2014: Infrastructure Gets Sexy, HCP Apps Steal the Show

November 13, 2014

Two of the industry's most influential conferences occurred within weeks of each other this autumn – TEDMED and Health 2.0. Bill Drummy reviews both events.

Medicare Part B Data: Approach with Care

November 12, 2014

CMS's Part B data release has increased transparency but has also resulted in potentially misplaced scrutiny of high-billing doctors. Ben Scher, Kathleen Twigg, and Andrew Huson take a closer look.

Dane in America: Novo Nordisk's Jesper Hoiland

November 3, 2014

Novo Nordisk's Senior VP for North America, Jesper Hoiland, discusses his first year on the job at Novo's regional HQ in Princeton, NJ, including an unsettling initial encounter with PBM medicines gatekeepers.

Industry Growth Slows in Brazil

November 1, 2014

The Brazilian economy is being impacted by internal and external factors, and forecast figures are being quickly revised downwards. Hellen Berger reports.

Closing Gaps in the Supply Chain

November 1, 2014

Cynthia Challener reports on the progress of the supply chain security and quality group, the Rx-360 Consortium, five years on from its establishment.

Pharma Science: It's Hard

November 1, 2014

Amid a resurgence in drug development for hard-to-treat conditions, the bigger question is whether the times are as good for the industry tasked with rendering basic science into therapeutically effective medicines.

EMA Clinical Data Disclosure Plan Under Fire

October 27, 2014

The EMA might have expected that the publication of its plan for proactive release of clinical reports would receive a warm welcome. But, Reflector writes, it is far from a roaring success.

TAG Touts Progress in Global Access to TB Drugs

October 14, 2014

TB advocacy campaigner Treatment Action Group (TAG) has reached a milestone in improving access to TB treatments. Casey McDonald reports.


Click here